Using machine learning to identify patients with cancer that would benefit from immunotherapy
A new study examines the development of two machine learning models to classify the immunophenotype of a cancer specimen.
Apr 16, 2024
0
0
Mary Ann Liebert Inc. was founded in 1980 by Mary Ann Liebert in New Rochelle, NY. The company publishes peer-reviewed journals, books and trade magazines in a variety of fields. A sample of journals, include Genetic Engineering & Biotechnology News, Human Gene Therapy and Women's Health. BioConferences International Inc. is a subsidiary of Mary Ann Liebert Inc. This company's focus is to organize symposiums and conferences in Biotechnology, Women's Health, Alternative Medicine, Law and more.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
A new study examines the development of two machine learning models to classify the immunophenotype of a cancer specimen.
Apr 16, 2024
0
0
Two new review articles in AI in Precision Oncology explore the role of artificial intelligence (AI) in early cancer detection. A primer provides an overview of AI, and the second review examines the promising clinical applications ...
Apr 11, 2024
0
1
A new study describes a novel surgical technique used to treat Moebius syndrome, a rare congenital condition leading to the inability to smile, oral incompetence, and a significant impact on social engagement. The study is ...
Mar 27, 2024
0
0
A new study published in the journal Diabetes Technology & Therapeutics has evaluated the use of tirzepatide in overweight/obese adults with type 1 diabetes. Tirzepatide is approved for managing type 2 diabetes. It improves ...
Mar 25, 2024
0
1
A new study has shown that overall and cause-specific mortality rates in individuals in the U.S. with low-risk differentiated thyroid cancer (DTC) are low. The study is published in Thyroid.
Mar 21, 2024
0
0